COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,627 Articles (22,913 medRxiv, 8,714 bioRxiv)

Most recent first Previous |  Page 1744: Articles 17431-17440  | Next

Seroreactivity to SARS-CoV-2 in individuals attending a university campus in Bogota Colombia
Gonzalez, J. M., Santos-Barbosa, J. C., Jaller, C., Otalora, G., Hernandez, L. J., Guevara-Suarez, M., Restrepo, S.
10.1101/2021.03.15.21253609 — Posted: 2021-03-17
Quantitative Comparison of SARS-CoV-2 Nucleic Acid Amplification Test and Antigen Testing Algorithms: A Decision Analysis Simulation Model
Salvatore, P. P., Shah, M. M., Ford, L., Delaney, A., Hsu, C. H., Tate, J. E., Kirking, H. L.
10.1101/2021.03.15.21253608 — Posted: 2021-03-17
Associations of the BNT162b2 COVID-19 vaccine effectiveness with patient age and comorbidities
Yelin, I., Katz, R., Herzel, E., Berman-Zilberstein, T., Ben-Tov, A., Kuint, J., Gazit, S., Patalon, T., Chodick, G., Kishony, R.
10.1101/2021.03.16.21253686 — Posted: 2021-03-17
Rapid base-specific calling of SARS-CoV-2 variants of concern using combined RT-PCR melting curve screening and SIRPH technology
Tierling, S., Kattler, K., Vogelgesang, M., Pfuhl, T., Lohse, S., Lo Porto, C., Schmitt, B., Salhab, A., Smola, S., Walter, J.
10.1101/2021.03.15.21253586 — Posted: 2021-03-17
Tocilizumab Effect in COVID-19 Hospitalized Patients: A Systematic Review and Meta-Analysis of Randomized Control Trials
Aletreby, W. T., Abdulrahman, B., Mady, A. F., Noor, A. M., Lhmdi, M. H., Faqihi, F., Alharthy, A. M., Al-Odat, M. A., Karakitsos, D., Memish, Z.
10.1101/2021.03.15.21253581 — Posted: 2021-03-17
Understanding Convergence Between Non-Hispanic Black and White COVID-19 Mortality: A County-Level Approach
Lawton, R. I., Zheng, K. Z., Zheng, D., Huang, E. S.
10.1101/2021.03.15.21253566 — Posted: 2021-03-17
Post-viral parenchymal lung disease of COVID-19 and viral pneumonitis: A systematic review and meta-analysis.
Fabbri, L., Moss, S., Khan, F., Chi, W., Xia, J., Robinson, K., Smyth, A., Jenkins, G., Stewart, I.
10.1101/2021.03.15.21253593 — Posted: 2021-03-17
COVID-19 and Cognitive Impairment: Severity, Evolution, and Functional Impact during Inpatient Rehabilitation
Patel, R., Savrides, I., Cahalan, C., Doulatani, G., O'Dell, M. W., Toglia, J., Jaywant, A.
10.1101/2021.03.15.21253637 — Posted: 2021-03-17
A Longitudinal Analysis of COVID-19 Lockdown Stringency on Sleep and Resting Heart Rate Measures across 20 Countries
Ong, J. L., Lau, T., Karsikas, M., Kinnunen, H., Chee, M. W. L.
10.1101/2021.03.15.21253668 — Posted: 2021-03-17
Characterizing altruistic motivation in potential volunteers for SARS-CoV-2 challenge trials
Rose, S. M., Schmit, V. L., Darton, T. C., Eyal, N., Magalhaes, M., Morrison, J., Peeler, M., Shah, S. K., Marsh, A. A.
10.1101/2021.03.14.21253548 — Posted: 2021-03-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).